Mumps News and Research

RSS

Mumps is a viral disease characterized by fever, headache, muscle weakness, stiff neck, loss of appetite, swelling and tenderness of one or more of the salivary glands situated along the angle of the jaw and inside the mouth, including the parotid gland located within the cheeks just below the front of the ear.

Researchers engineer promising live-attenuated RSV vaccine candidate

Crafting a vaccine against RSV (respiratory syncytial virus) has been a minefield for 50 years, but scientists believe they have found the right balance.

21 Dec 2016

Texas A&M specialist explains what people need to know about mumps

Mumps may seem like a contagion relegated to history books, but like many other diseases of the past now preventable with a vaccine, mumps has been making a resurgence.

20 Dec 2016

Awareness of signs and symptoms of meningitis remains worryingly low among UK parents, research reveals

Thirty-eight per cent of parents in the UK think a distinctive rash is the first symptom of meningitis, despite the fact it often appears after other symptoms, or not at all, according to new research from GSK.

26 Nov 2016

Vaccine-related rubella virus causes harm in some patients with primary immunodeficiency disorders

Some patients with rare primary immunodeficiency disorders may be at risk for infection by rubella virus, and possibly serious skin inflammation, after receiving the rubella vaccine, usually administered as part of the measles-mumps-rubella (MMR) vaccine.

7 Nov 2016

Measles complication that kills children more common than previously thought

A complication of measles that kills children years after they have the infection is more common than thought, according to a study being presented at IDWeek 2016.

31 Oct 2016

Region of the Americas becomes first in world to eradicate measles

The Region of the Americas is the first in the world to have eliminated measles, a viral disease that can cause severe health problems, including pneumonia, blindness, brain swelling and even death. This achievement culminates a 22-year effort involving mass vaccination against measles, mumps and rubella throughout the Americas.

30 Sep 2016

Tips to prevent back-to-school illnesses in children

The backpacks are packed, lunchboxes are filled and the little ones are back in school. Kids have returned to their classrooms with stories of their summer vacations, and, unfortunately, with a host of germs ready to spread quickly in a close environment.

20 Sep 2016

Pre-travel consultation can help international travelers to prepare for trip

International tourism exceeds 1.2 billion persons each year, with more than 20 percent of travelers reporting some type of illness.

31 Aug 2016

Mayo Clinic expert offers tips to avoid illness at major events

Zika isn't the only health concern now that the games have begun in Rio. Massive crowds from around the globe will be at the Olympics, and that means a world-class array of germs will mix with them.

8 Aug 2016

Clinical trial to test safety, efficacy of Roswell Park-developed SurVaxM in multiple myeloma patients

An immune-based therapy developed at Roswell Park Cancer Institute is moving forward with its third clinical trial. The early-stage clinical trial will assess whether SurVaxM — a cancer vaccine developed at Roswell Park — is a safe and effective treatment option for patients with multiple myeloma, a rare type of blood cancer.

1 Jun 2016

Doctor’s access to vaccination data can improve pediatric immunization coverage

Exchange of immunization data between a centralized city immunization registry and provider electronic health records led to significant improvements in pediatric immunization coverage, a reduction in over-immunization for adolescents, and increased completeness of immunization records, according to a study conducted at Columbia University's Mailman School of Public Health, Columbia University Medical Center, NewYork-Presbyterian, and the New York City Department of Health and Mental Hygiene's Citywide Immunization Registry.

6 May 2016

First-ever vaccine to combat Leishmaniasis under development

As scientists scramble to get a Zika virus vaccine into human trials by the end of the summer, a team of researchers is working on the first-ever vaccine to prevent another insect-borne disease - Leishmaniasis - from gaining a similar foothold in the Americas.

27 Apr 2016

High-throughput RNA interference screen identifies potential drug target against henipaviruses

The closely related Hendra and Nipah viruses (referred to jointly as henipaviruses) are deadly cousins of the more common mumps, measles, and respiratory syncytial viruses, all members of the paramyxovirus family. Henipavirus outbreaks are on the rise, but little is known about them, partly because research has to be conducted under extreme level containment conditions.

28 Mar 2016

Blueberry Therapeutics set to create safe, effective nanomedicines to tackle unmet healthcare needs

Blueberry Therapeutics Ltd, a leading pharmaceutical company focused on the major medical problems of inflammation and infection, are exploring the anti-microbial agenda through the development of new anti-fungal drugs and treatments to tackle this important unmet healthcare need.

2 Mar 2016

New WHO report highlights ways to prevent, mitigate hearing loss in children

Nearly 32 million children across the world live with disabling hearing loss. A new World Health Organization (WHO) report, Childhood hearing loss: act now, here’s how, suggests that 60% of this can be prevented.

2 Mar 2016

Cryo-electron microscopy helps analyze infection mechanisms of coronaviruses in detail

High-resolution cryo-electron microscopy and supercomputing have now made it possible to analyze in detail the infection mechanisms of coronaviruses. These viruses are notorious for attacking the respiratory tract of humans and animals.

27 Feb 2016

Alternatives exist to eliminate nonmedical exemptions for childhood vaccination

For more than 30 years, Mississippi and West Virginia were the only states in the country that disallowed nonmedical exemptions to mandatory school vaccination laws for religious or philosophical reasons, until they were joined by California last year. These exemption laws have provoked debate over the rights of parents versus the responsibility of government to protect public health.

9 Feb 2016

CFDA issues new drug certificate and production license for Sinovac's EV71 vaccine

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, today announced that the China Food and Drug Administration issued the new drug certificate and production license for its Enterovirus 71 ("EV71") vaccine.

4 Jan 2016

Sinovac gets approval to begin clinical trials on Sabin Inactivated Polio Vaccine candidate

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, today announced that the Company has obtained approval to begin human clinical trials on its Sabin Inactivated Polio Vaccine (or "sIPV") candidate.

10 Dec 2015

Recommendations for caring for Syrian refugees' health care needs

What unique health needs will Syrian refugees face, and how can Canadian physicians best provide health care to them and their families? A practice article posted online today in CMAJ (Canadian Medical Association Journal) provides recommendations on screening and advice for primary care physicians to deal with this specific population's health care needs.

9 Dec 2015